Alzheimer's Disease Trial, Recruiting (NCT07289061)

Alzheimer's Disease Trial, Recruiting NCT07289061 Sponsor: Aristotle University Of Thessaloniki Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07289061 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been formally diagnosed with either Subjective Cognitive Decline (meaning you notice memory or thinking changes yourself) or Mild Cognitive Impairment (meaning tests show some mild thinking or memory changes), based on a clinical assessment.

Who may not be able to join:

You have been diagnosed with dementia or a moderate to severe disorder affecting your thinking and memory.
You currently have an unstable or untreated serious mental health condition, such as severe depression with psychosis, bipolar disorder, or schizophrenia.
You have a neurological condition (a condition affecting the brain or nervous system) that impacts your thinking or memory (confirm with trial site).
You have hearing or vision problems that have not been corrected and that would make it difficult to take part in assessments or online sessions.
You are currently taking part in another research study that is also looking at improving thinking, memory, or wellbeing.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 30 June 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07289061

Sponsor: Aristotle University Of Thessaloniki

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

More information: https://clinicaltrials.gov/study/NCT07289061

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been formally diagnosed with either Subjective Cognitive Decline (meaning you notice memory or thinking changes yourself) or Mild Cognitive Impairment (meaning tests show some mild thinking or memory changes), based on a clinical assessment.

Who may not be able to join:

You have been diagnosed with dementia or a moderate to severe disorder affecting your thinking and memory.
You currently have an unstable or untreated serious mental health condition, such as severe depression with psychosis, bipolar disorder, or schizophrenia.
You have a neurological condition (a condition affecting the brain or nervous system) that impacts your thinking or memory (confirm with trial site).
You have hearing or vision problems that have not been corrected and that would make it difficult to take part in assessments or online sessions.
You are currently taking part in another research study that is also looking at improving thinking, memory, or wellbeing.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 30 June 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Aristotle University Of Thessaloniki

Registry

ClinicalTrials.gov

Start date

17 December 2025

Est. completion

1 June 2027

Where this trial is recruiting

🇬🇷 Greece

Primary endpoints

Global cognitive composite (z-score) from REMEDES4Alzheimer; Resting-state fNIRS functional connectivity (HbO) between bilateral dorsolateral prefrontal cortices; EEG alpha power at rest (eyes-closed)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov